These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11589688)

  • 1. Marimastat therapy as adjuvant to selective embolization in skeletal metastases of differentiated thyroid carcinoma.
    Smit JW; van Tol KM; Hew JM; Vielvoye GJ; Romijn JA; Links TP
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):421-2. PubMed ID: 11589688
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer.
    Shepherd FA; Giaccone G; Seymour L; Debruyne C; Bezjak A; Hirsh V; Smylie M; Rubin S; Martins H; Lamont A; Krzakowski M; Sadura A; Zee B
    J Clin Oncol; 2002 Nov; 20(22):4434-9. PubMed ID: 12431965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is British Biotech's Marimastat a major cancer drug?
    Davidson S
    Nat Biotechnol; 1996 Jul; 14(7):819-20. PubMed ID: 9630998
    [No Abstract]   [Full Text] [Related]  

  • 4. Embolization in combination with radioiodine therapy for bone metastases from differentiated thyroid carcinoma.
    Van Tol KM; Hew JM; Jager PL; Vermey A; Dullaart RP; Links TP
    Clin Endocrinol (Oxf); 2000 May; 52(5):653-9. PubMed ID: 10792347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective embolization for hypervascular metastasis from differentiated thyroid cancer: a case series.
    Son HY; An SY; Kim EY; Ahn SB; Lee BC
    J Med Case Rep; 2014 Dec; 8():405. PubMed ID: 25471328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised double blind placebo control study of adjuvant treatment with the metalloproteinase inhibitor, Marimastat in patients with inoperable colorectal hepatic metastases: significant survival advantage in patients with musculoskeletal side-effects.
    King J; Zhao J; Clingan P; Morris D
    Anticancer Res; 2003; 23(1B):639-45. PubMed ID: 12680160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Embolization of skeletal metastases in patients with differentiated thyroid carcinoma].
    Smit JW; Links TP; Hew JM; Goslings BM; Vielvoye GJ; Vermey A
    Ned Tijdschr Geneeskd; 2000 Jul; 144(29):1406-10. PubMed ID: 10923150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marimastat (BB2516): current status of development.
    Steward WP
    Cancer Chemother Pharmacol; 1999; 43 Suppl():S56-60. PubMed ID: 10357560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marimastat in patients with advanced pancreatic cancer: a dose-finding study.
    Rosemurgy A; Harris J; Langleben A; Casper E; Goode S; Rasmussen H
    Am J Clin Oncol; 1999 Jun; 22(3):247-52. PubMed ID: 10362330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embolization therapy of bone metastases from epithelial thyroid carcinoma: effect on symptoms and serum thyroglobulin.
    De Vries MM; Persoon AC; Jager PL; Gravendeel J; Plukker JT; Sluiter WJ; Links TP
    Thyroid; 2008 Dec; 18(12):1277-84. PubMed ID: 18991486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma.
    Eustatia-Rutten CF; Romijn JA; Guijt MJ; Vielvoye GJ; van den Berg R; Corssmit EP; Pereira AM; Smit JW
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3184-9. PubMed ID: 12843163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dupuytren's disease and frozen shoulder induced by treatment with a matrix metalloproteinase inhibitor.
    Hutchinson JW; Tierney GM; Parsons SL; Davis TR
    J Bone Joint Surg Br; 1998 Sep; 80(5):907-8. PubMed ID: 9768907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects between marimastat, a TNF-alpha converting enzyme inhibitor, and anti-TNF-alpha antibody on murine models for sepsis and arthritis.
    Tsuji F; Oki K; Okahara A; Suhara H; Yamanouchi T; Sasano M; Mita S; Horiuchi M
    Cytokine; 2002 Mar; 17(6):294-300. PubMed ID: 12061836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies.
    Nemunaitis J; Poole C; Primrose J; Rosemurgy A; Malfetano J; Brown P; Berrington A; Cornish A; Lynch K; Rasmussen H; Kerr D; Cox D; Millar A
    Clin Cancer Res; 1998 May; 4(5):1101-9. PubMed ID: 9607566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Images in thyroidology. Embolization of a bone metastasis of follicular thyroid carcinoma.
    van Tol KM; Hew JM; Links TP
    Thyroid; 2000 Jul; 10(7):621-2. PubMed ID: 10958316
    [No Abstract]   [Full Text] [Related]  

  • 16. Marimastat inhibits neointimal thickening in a model of human arterial intimal hyperplasia.
    Peterson M; Porter KE; Loftus IM; Thompson MM; London NJ
    Eur J Vasc Endovasc Surg; 2000 May; 19(5):461-7. PubMed ID: 10828225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marimastat. BB 2516, TA 2516.
    Drugs R D; 1999 Feb; 1(2):146-9. PubMed ID: 10566011
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumour marker levels during marimastat therapy.
    Gore M; A'Hern R; Stankiewicz M; Slevin M
    Lancet; 1996 Jul; 348(9022):263-4. PubMed ID: 8684209
    [No Abstract]   [Full Text] [Related]  

  • 19. Transarterial embolization of primary and secondary tumors of the skeletal system.
    Radeleff B; Eiers M; Lopez-Benitez R; Noeldge G; Hallscheidt P; Grenacher L; Libicher M; Zeifang F; Meeder PJ; Kauffmann GW; Richter GM
    Eur J Radiol; 2006 Apr; 58(1):68-75. PubMed ID: 16413155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent advances in the treatment of bone metastases from cancer of the thyroid (author's transl)].
    Camille RR; Leger FA; Merland JJ; Saillant G; Savoie JC; Riche MC
    Chirurgie; 1980 Jan; 106(1):32-6. PubMed ID: 7379630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.